DP

Duvvury Penta Babu

Director Director DIN 02434584
DIN 02434584 First appointment Dec 2008 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Dec 2008
Shareholding value •••• Premium profile

About Duvvury Penta Babu

Data last updated:

Duvvury Penta Babu was a Director at Chandra Life Sciences Private Limited (2008–2010) and Director at Stein Pharma Private Limited (2011–2018). The companies operate in Pharma.

DIN 02434584
Primary Designation Director
Industry Pharma
First Appointment 01 Dec 2008

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director01 Dec 20082007₹63.01 Cr (FY 2024)Active
Stein Pharma Private Limited U24232TG2010PTC068377
Director17 Oct 20112010₹12.77 Cr (FY 2017)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Chandra Life Sciences Private Limited
Stein Pharma Private Limited
Premium access

Shareholding and investment profile for Duvvury Penta Babu

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Duvvury Penta Babu

Duvvury Penta Babu was first appointed on 01 Dec 2008 as Director at Chandra Life Sciences Private Limited. The most recent appointment on record is 17 Oct 2011 at Stein Pharma Private Limited.

Duvvury Penta Babu held 2 earlier board appointments: Chandra Life Sciences Private Limited (Director, 01 Dec 2008 to 15 May 2010); Stein Pharma Private Limited (Director, 17 Oct 2011 to 05 Sep 2018).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available